CN Patent

CN102105059A — 用于睡眠障碍和其他疾病的方法和组合物

Assigned to Intra Cellular Therapies Inc · Expires 2011-06-22 · 15y expired

What this patent protects

本发明涉及特定取代的杂环稠合γ-咔啉作为药物和包含所述化合物的药物组合物用于治疗涉及5-HT 2A 、SERT和/或多巴胺D 2 通路的一种或多种障碍的用途。此外，该化合物可以联合其他治疗剂用于治疗一种或多种睡眠障碍、抑郁、精神病、运动障碍和/或帕金森病或任何组合。

USPTO Abstract

本发明涉及特定取代的杂环稠合γ-咔啉作为药物和包含所述化合物的药物组合物用于治疗涉及5-HT 2A 、SERT和/或多巴胺D 2 通路的一种或多种障碍的用途。此外，该化合物可以联合其他治疗剂用于治疗一种或多种睡眠障碍、抑郁、精神病、运动障碍和/或帕金森病或任何组合。

Drugs covered by this patent

lumateperone-tosylate (LUMATEPERONE TOSYLATE)

Patent Metadata

Patent number: CN102105059A
Jurisdiction: CN
Classification: —
Expires: 2011-06-22
Drug substance claim: No
Drug product claim: No
Assignee: Intra Cellular Therapies Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.